Table 2.
Supervised Models | ||||||
---|---|---|---|---|---|---|
N | R2X | R2Y | Q2 | p-Value | Permutation Test: Intercept R2\Q2 |
|
C vs. Hom vs. Het | 39 | 0.351 | 0.484 | 0.159 | ns | 0.27/−0.14 |
Het vs. Hom | 13 | 0.515 | 0.699 | 0.246 | ns | 0.73/−0.03 |
C vs. Het | 34 | 0.352 | 0.689 | 0.390 | 0.003 | 0.44/−0.21 |
C vs. Hom | 33 | 0.486 | 0.917 | 0.658 | <0.0001 | 0.55/−0.33 |
C= control patients; Het = heterozygous for β-thalassemia patients; Hom = homozygous for β-thalassemia patients; N, number of samples; R2X, R2Y, values indicating the variance of the model; Q2, value indicating the predictive ability of the model. The p-value was considered significant for values <0.05.